Pharma faces more deceptive-marketing charges from states

04/23/2013 | Wall Street Journal, The

The pharmaceutical industry's potential liability widened after some U.S. states showed more aggressiveness in accusing drugmakers of deceptive marketing. Certain states have opted to act alone, which has led to heavy settlements and single-state awards. Matthew Bennett, senior vice president of the Pharmaceutical Research and Manufacturers of America, said "imposing state-law penalties on manufacturers for alleged violations of [federal drug law] raises serious legal and constitutional questions."

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA